Background/Aims: Chronic kidney disease (CKD) is closely correlated with the development of insulin resistance (IR). Until now, the underlying molecular mechanisms remain to be elucidated. This study aimed to identify metabolites and molecular pathways unique to CKDinduced IR. Methods: Ultra-performance liquid chromatography-tandem mass spectrometer (UPLC-MS) analysis coupled with orthogonal partial least square discriminant analysis (OPLS-DA) were performed to profile metabolites in the serum, liver, and muscle tissues and to analyze molecular pathways in relation to CKD-and high fat diet (HFD)-induced IR in the rats. Results: At 18 weeks after the 5/6 Nx operation, CKD induction was demonstrated by renal histology and biochemical tests. Furthermore, both CKD-induced IR and HFD-induced IR rats showed significantly greater levels of fasting insulin and homeostasis model assessment of insulin resistance (HOMA-IR). In the UPLC-MS in combination with OPLS-DA analysis, we identified 101, 59, and 41 differential metabolites in the serum, liver, and muscle, which were associated with the CKD-induced IR, while 58, 38, and 17 differential metabolites in the serum, liver, and muscle were revealed in the HFD-induced rats compared to controls. Moreover, compared to HFD-induced IR rats, those with CKD-induced IR exhibited abnormal pathways primarily in the tryptophan metabolism, arginine metabolism, and trimethylamine oxide metabolite. Interestingly, altered metabolites in the CKD-induced IR and HFD-induced IR displayed an opposite direction. Conclusion: Alterations in metabolites and relevant pathways were significantly different between the CKD-and HFD-induced IR rats. These findings may
Introduction
Chronic kidney disease (CKD) represents a serious health problem worldwide, affecting approximately 5-10% of the world population [1, 2] . Clinical studies have noted that the development of insulin resistance (IR) is highly prevalent among patients with renal dysfunction, usually presenting with hyperglycemia, glucose intolerance, hyperinsulinemia, and dyslipidemia [3] . In addition, an increasing body of evidence suggests that a decline in kidney function among CKD patients is significantly correlated with the development of IR, which is characterized by the impairment of insulin signaling, glucose utilization and metabolism of its target organs, primarily including the liver and skeletal muscle [3, 4] . Moreover, IR in CKD has been identified to be an independent risk factor for other CKDassociated diseases such as cardiovascular disease, greatly contributing to the cardiovascular burdens of patients with CKD [5] . The kidney is an important organ in glucose homeostasiss [6] . Turnover studies using isotope-labeled glucose conducted by Cersosimo and colleagues have demonstrated that glucose utilization and production in the kidney were relevant components of glucose metabolism in humans [7] . Until now, the underlying causes and molecular pathways whereby CKD induces IR remain largely unknown. Therefore, it is pivotal to identify and characterize the molecules and molecular pathways that are specific to IR induced by CKD.
A great number of studies over decades have demonstrated that excessive dietary fat has been well-established to be a common driver of IR [8, 9] . Notably, rats fed a high-fat diet comprising of 59% fat and 20% carbohydrates for as short as 3 weeks developed IR and exhibited declines in the biological action of insulin in both target organs, i.e., the liver and the skeletal muscle [9] , and interestingly, saturated fat appeared to be more effective than unsaturated fat in inducing IR in rats [9] . Similar to the animal studies, IR was found to be positively associated with dietary fat intake and excessive body weight in humans [10] . Recent years have witnessed major progress in understanding the pathways and molecular mechanisms whereby a high fat diet (HFD) induces IR in animal models for IR. However, how impaired kidney function and CKD lead to IR remains to be elucidated. The reduction in renal function in patients suffering from CKD is known to result in considerable changes in body homeostasis, which may in turn affect insulin sensitivity of the liver and muscle tissues. Therefore, understanding the underlying molecules and pathways may provide novel preventive and therapeutic approaches to reducing the development of IR among patients diagnosed with CKD.
Mass spectrometry (MS)-based metabonomics [11] [12] [13] [14] , a recently developed technology, has enabled us to generate a vast amount of data on metabolites and to quantitatively analyze the metabolites that are affected by CKD and thus could contribute to the development of IR in CKD. To date, there have been no metabonomic studies to comparatively profile the metabolites of IR caused by CKD (CKD-induced IR) and an excessively high-fat diet (HFDinduced IR). This study aimed to identify the metabolites and molecular pathways specific to CKD-induced IR in rats by performing ultra-performance liquid chromatographytandem mass spectrometer (UPLC-MS) analysis coupled with orthogonal partial least square discriminant analysis (OPLS-DA). We hypothesized that the molecular mechanisms underlying CKD-induced IR are distinct from those in HFD-induced IR, which was relatively well-understood. Thus, in this study, we examined and compared alterations in metabolites of the serum, liver, and muscle samples between CKD-induced IR versus HFD-induced IR. The comparative results may offer important information regarding unique pathogenic mechanisms in relation to IR caused by a decline in the renal function or CKD-induced
Biochemical tests
Blood samples were obtained from the SD rats in the following four groups: Sham + SCD, Nx + SCD, Sham + HFD, and Nx + HFD. Biochemical tests were performed to examine the serum levels of molecules related to IR, kidney function, and the lipid parameters. A 24 h urine samples were also collected from the studied SD rats to determine the volume of urine and the total protein excretion from the urine.
Histological examination
Upon completing the experiments, the SD rats were sacrificed, and their kidney and liver tissues were collected from the four groups. The sections of rat kidney were prepared according the standard protocol in our laboratory, followed by staining with PAS and Masson for the renal tissues. The resulting slides were visualized and analyzed under microscope according to the manufacturer's instructions by an expert who was blinded to the studied groups.
Insulin resistance analysis
The homeostasis model assessment of insulin resistance (HOMA-IR), a well-accepted model for analysis of IR [18] , was used in this study to determine IR in the studied rats. In brief, following an overnight fasting, levels of glucose were determined, and insulin concentrations were examined using an ELISA kit (Mercodia, Uppsala, Sweden). The values of HOMA-IR were calculated and obtained according to the formula: fasting insulin (microU/L) x fasting glucose (mmol/L)/22.5.
Intraperitoneal glucose tolerance test (IPGTT)
For IPGTT, the studied rats were fasted overnight (16 h), following which they were injected intraperitoneally with 50% glucose (2 g/kg body weight). Blood samples were collected through the tail vein, and levels of blood glucose were determined by a glucometer (ACCU-CHEK Performa, Roche, USA) before and after glucose injection at different time points (30, 60, 90 , and 120 min). The total area under the curve (AUC) was calculated for IPGTT.
Insulin tolerance tests (ITTs)
For ITTs, the studied rats were fasted for 6 h, following which they were injected intraperitoneally with human insulin (Novolin R, Novo Nordisk, Copenhagen, Demark) at a dose of 0.75 U/kg body weight. Blood samples were drawn via the tail vein at different time points (0, 15, 30, 45, 60, and 90 min) for subsequent measurement of blood glucose concentrations with a glucometer (ACCU-CHEK Performa, Roche, USA).
Metabonomic profiling by UPLC-MS
Metabolites in the serum, liver, and muscle tissues collected from the studied rats were profiled by performing UPLC-MS analysis. Briefly, the liver and muscle samples were homogenized completely and centrifuged to generate supernatant. The resulting clear supernatant of the serum, liver, and muscle samples was transferred into the UPLC vials. Prior to examination of the experimental samples, quality controls were run to stabilize the HPLC equipment. For screening on untargeted metabolites, in positive mode, Atlantis HILIC Silica column (Waters, USA) was used; in negative mode, a BEH Amide column (Waters, USA) was used for metabolites separation. The MS methods were conducted on Q Extract Orbitrap MS screening according to the manufacturer's manual. To screen the targeted metabolites, Synergi Hydro-RP 100A column (Phenomenex, USA) and TSQ Quantiva Triple Quadrupole MS (Thermo Fisher, CA) with positive/ negative ion switching were used.
Metabolite identification and metabolic pathway analysis
Tracefinder (Thermo, CA) software was used to analyze data-dependent MS/MS acquisition. Briefly, the mass of each metabolite was initially determined according to the endogenous MS database and subsequently confirmed with a fragments database. For the mass spectra produced by a mass spectrometer, the error of the precursor ion was set to 5 ppm with that of the fragment ion as 15 ppm, while a retention time of 0.25 min was used for quantitative analysis.
An orthogonal partial least square discriminant analysis (OPLS-DA) was used to conduct the supervised analysis. The PLS-DA models were confirmed by 200× permutation testing. Each model's predictive ability was evaluated by the leave-one-out analysis. A non-parametric U Mann-Whitney analysis was applied to compare peak integrals. To examine alterations in metabolites of the serum, liver, and muscle samples between CKD-and HFD-induced IR, a foregoing analysis was re-performed on two sensitivity subgroups. For the analysis of the metabonomic pathways, levels of the key metabolites before and after applying the sensitivity analysis were entered into an online computational analysis tool, MetaboAnalyst 3.0, which allows integrating enrichment analysis with topology analysis to identify the most relevant pathways affected. The main settings used for the analysis were as follows: species (rat), algorithm of the pathway enrichment analysis (Global Test), and algorithm of the pathway topology analysis (Relative-betweenness Centrality).
Statistical analysis
Statistical analysis was conducted using IBM SPSS20.0 from SPSS Inc. (Chicago, IL, USA), and a two-way analysis of variance was used to initially determine normally distributed original data. Student's t-test was used to analyze differences between two groups. P<0.05 was set as statistically significant.
Results

Characterization and validation of rat models for CKD, CKD-, and HFD-induced insulin resistance
The male SD rats underwent the 5/6 nephrectomy (5/6 Nx) or a sham surgery (Sham) as control, and the induction of CKD was evaluated by histological examination of the renal tissue sections and biochemical tests for renal function. As shown in Fig. 1a -h, the rats in the 5/6 Nx group exhibited glomerular hypertrophy and sclerosis, mesangial expansion as measured by the PAS staining, as well as glomerular fibrosis, tubular atrophy, inflammatory cell infiltration and fibrosis in the renal interstitium as examined by the Masson's staining compared with those in the sham group. The renal histologic images were further quantitatively analyzed, indicating that both glomerulosclerosis and tubulointerstitial injury scores in the Nx+SCD and Nx+HFD groups were significantly greater than those in the Sham+SCD and Sham+HFD groups (P<0.01) (Suppl. Fig. 1 ). For all supplemental material see www. karger.com/doi/10.1159/000492247. In the biochemical tests, the 5/6 Nx rats displayed a decline in creatinine clearance (Suppl. Table 1 ) but an increase in the 24 h urine protein excretion (Fig.  1i, j) . As expected, the visceral fat to the body weight ratio was significantly greater in the Sham+HFD and Nx+HFD groups compared to the Sham+SCD and Nx+SCD groups, while the left/ right kidney weight in the Nx+SCD and Nx+HFD groups was significantly higher than the Sham+SCD and Sham+HFD groups (Suppl. Table 2 ). The above morphological and biochemical changes in the rats that underwent 5/6 Nx have been well-recognized as the main typical characteristics of CKD and therefore confirmed the successful preparation of the rat models for CKD in this study.
IR analysis of IPGTT, insulin tolerance tests (ITTs), as well as the values of the HOMA-IR index was conducted to determine CKD-and HFD-induced insulin resistance. After injected intraperitoneally with glucose, the Nx+SCD group exhibited impaired glucose clearance in contrast to the Sham+SCD group, and the difference between the two groups was significant (P<0.01) (Fig. 2a, b) . Disturbances in glucose clearance were also found in the Nx+HFD (Fig. 2a, b) . The 5/6 Nx rats fed with SCD showed a significantly greater HOMA-IR index compared to the sham rats given the same chow (P<0.05) (Fig.  2c) . Similar results with significant increases in the HOMA-IR index were observed in the rats fed with HFD versus SCD, and the differences were statistically significant (P<0.01) (Fig. 2c) . As shown in Fig. 2d and 2e, the glucose-lowing effects of insulin were impaired in the Nx+SCD group versus Sham+SCD group, and the Sham+HFD group versus Sham+SCD group with significant differences observed at 90 min post injection of insulin (P<0.05). These results obtained from IPGTT, ITTs, and HOMA-IR index indicated that the rat models for CKD-and HFDinduced IR were successfully established.
Primary metabonomic analysis by UPLC-MS
UPLC-MS analysis of metabolites in the serum, liver, and muscle tissues obtained from the studied rats was performed, and representative spectra were displayed in Fig. 3 . The score plots generated from the supervised OPLS-DA method were conducted on the metabolite profiling data of the serum, liver, and muscle samples in both the non-targeted and targeted detection modes (Fig. 4) , exhibiting an apparent discrimination among the four groups (Fig. 4) . In parallel, a clustering heatmap was used to visualize directly the results of multi-group analysis. Changes of each metabolite across the four different study groups were illustrated in Suppl. Fig. 2 . The statistically changed metabolites of the serum, liver, and muscle in both CKD and HFD rats were listed in Suppl. Tables 3, 4 , and 5.
After performing UPLC-MS analysis, we identified 293 compounds in the serum, of which 178 were detected in the non-target positive ion detection mode and 157 in the nontarget negative ion detection mode while 42 were overlapped; In parallel, 334 compounds were identified in the liver with 223 detected in the non-target positive detection mode, 149 in the target detection mode, and 38 overlapped; Similarly, with UPLC-MS, we identified 263 compounds in the muscle tissue; of these, 164 were captured in the non-target positive detection mode, 130 in the target detection mode, and 31 were overlapped. Characterization of the identified compounds revealed that they were primarily organic acids with small molecular weight, fatty acids, amino acids, carbohydrates, nucleotides, cofactors, vitamins, amines, etc.. 
Identification of abnormal metabolites and pathways in relation to CKD-induced IR
Based on comparing the differential metabolites identified above, the major altered metabolites in relation to CKDinduced IR were summarized as follows: 1) The top five serum metabolites with the highest fold increases were L-acetylcarnitine, ribothymidine, homocitrulline, 4-guanidinobutanoic acid, and cis-aconitic acid, while alpha-tocopherol, carnosine, 1 7 a -h y d r o x y p r e g n e n o l o n e , pregnenolone, and tetrah y d r o d e o x y c o r t i c o s t e r o n e decreased most in the CKD-induced IR group compared to the Sham group. 2) The major metabolites in the liver tissues including trigonelline, ergothioneine, N-acetylornithine, alpha-tocopherol, and eicosapentaenoic acid increased most, while 5-aminoimidazole-4-carboxamide-1-beta-d-ribofuranosyl 5'-monophosphate, N-palmitoylsphingosine, pyruvic acid, creatine and oleoyl ethanolamide decreased most in the CKD-induced IR group versus the Sham group.
3) The levels of the metabolites such as metformin, FAD, linoleoyl ethanolamide, dIMP, and hypotaurine remained significantly lower in the muscle tissues in the CKD-induced IR rats compared with the Sham rats, whereas allantoin, 4-guanidinobutanoic acid, 2-phenylglycine, homocitrulline, and imidazoleacetic acid were found to be significantly greater in the CKD-induced IR rats than the Sham rats. 
Identification of abnormal metabolites and pathways correlated with high-fatinduced IR
Similarly, we performed a direct comparison of the metabolites between the HFDinduced IR and control groups, and the major results were summarized as follows: 1) The serum levels of taurocholic acid, gluconic acid, pipecolic acid, xanthine, and oxypurinol increased most in the HDFinduced IR group versus the SCD group, while serum trigonelline, ergothioneine, N -a c e t y l o r n i t h i n e , alpha-tocopherol, and eicosapentaenoic acid were significantly decreased. 2) The hepatic metabolites with the highest fold increases included taurine, orotate, homocitrulline, (2-aminoethyl) phosphonate and 3-phosphoglycerate, and those with the highest fold decreases were trigonelline, ergothioneine, N-acetylornithine, 15-Deoxy-d-12, 14-PGJ2, and LysoPC (20:0) in relation to HDF-induced IR group; 3) The levels of N-acetylornithine, ergothioneine, trigonelline, Trimethylamine N-oxide, and methacholine were significantly lower in the muscle tissues in the HDFinduced IR rats compared with the SCD rats, whereas only three metabolites, including 2-phenylglycine, CDP-ethanolamine and adipic acid, were found to be significantly higher in the HDF-induced IR than the SCD rats. Notably, the above altered metabolites participated in multiple biological processes or metabolic pathways and the main metabolic pathways that were disturbed by HFDinduced IR are illustrated in Suppl. Tables 9, 10 , and 11.
Determination of the difference in altered metabolites and pathways between CKD-and highfat-induced IR in rats
We next comparatively profiled the metabolites and pathways of CKD-induced IR and HFD-induced IR in rats. The key differential metabolites from the IR caused by various factors related to the decline in kidney function and high-fat diet were identified and listed in Suppl. Tables 6, 7 , 8, 9, 10, and 11. Notably, the CKDinduced IR from HFD-induced IR in rats shared common changes in metabolites. A total of 101, 59, and 41 differential metabolites in the serum, liver, and muscle were associated with the CKD-induced IR, while 58, 37, and 17 differential metabolites in the serum, liver, and muscle, respectively, were revealed in the HFD-induced rats compared to controls. Moreover, compared to the HFDinduced IR rats, those with CKD-induced IR exhibited abnormal pathways primarily in the tryptophan metabolism, arginine metabolism, and trimethylamine oxide metabolite. Notably, the serum tryptophan metabolome identified significant alterations in metabolites specific to CKD-induced IR or HFD-induced IR in rats, with significant increases in 3-hydroxyanthranilic acid, serotonin, indoleacetaldehyde, kynurenic acid, and indoxyl sulfate significantly in the CKD-induced IR rats, with significant decreases in indoleacrylic acid, L-kynurenine, and 5-hydroxyindoleacetic acid in the HFD-induced rats (Fig. 5) . Furthermore, some of the altered metabolites in the CKD-and HFD-induced IR displayed an opposite direction. 
Discussion
This study comparatively profiled the metabolites in the serum, liver, and muscle tissues from CKD-induced IR and HFD-induced IR rats using UPLC-MS in combination with OPLS-DA analysis. The major novel findings were briefly summarized as follows: (1) Alterations in the metabolites of the serum, liver and muscle tissues were significantly different between the CKD-and HFD-induced IR rats; (2) compared with HFD, a decline in the renal function exhibited significant effects on the metabolic pathways, primarily in tryptophan and arginine metabolism; (3) some of altered metabolites in the CKD-induced IR versus HFD-induced IR displayed an opposite direction, implicating distinct molecular mechanisms underlying IR induced by diverse causes.
IR has long been observed as a common feature of CKD, and the decline in the kidney function in patients with CKD is closely correlated with the development of IR. IR has also been identified to be an independent risk factor to increase cardiovascular morbidity and mortality in CKD [19] . However, to date, the molecular mechanisms underlying CKDinduced IR have been poorly elucidated despite being explored in studies using cellular and experimental animal models over the last two decades [20] [21] [22] [23] . In particular, the combination of high-resolution MS and gene sequencing with bioinformatics analytic tools has accelerated the pace in understanding the more detailed composition in the uremic retention molecules (URMs) and intestinal microbiota and has contributed insight into their roles in the regulation of insulin sensitivity in the muscle and liver, which are well known as major target organs of insulin and energy metabolism. A wealth of evidence has indicated that endogenous URMs produced by gut microbiota or tissue metabolism were likely to be important molecules in disturbing insulin signaling pathways. McCaleb and colleagues found that adipocytes after incubation with serum from the CKD patients were capable of suppressing insulin-stimulated glucose uptake. Interestingly, a parallel experiment in which adipocytes incubated with serum from diabetic or obese patients without signs of renal function impairment did not show such an effect [24] . A recent study performed by Koppe et al. found that a uremic toxin originating from tyrosine metabolism, known as p-cresyl sulfate (PCS), played an important role in CKD-associated IR in mice [4, 25] . They further demonstrated that PCS affected insulin signaling, which was mediated by the direct activation of ERK1/2 [25] . The above findings have greatly advance our understanding regarding the mechanisms underlying uremia-induced IR and have highlighted an important role for individual uremic toxins in the development of IR in animals. The above results also suggested that differential URMs, metabolic molecules, and pathways that were specific to declining renal function in CKD may be involved in CKD-induced IR. Other mechanisms have been proposed in explaining the development of IR in CKD [26] [27] [28] [29] . It was of note that adipose tissue, which disposes of approximately 2% oral glucose load, also participates in an increase in IR, together with primary sites for IR, including the liver and muscle tissues [26] . It has also been demonstrated that an accumulation of asymmetric dimethylarginine (ADMA) in the adipose tissue of the rats following nephrectomy was linked to the development of IR through suppressing insulin-induced signaling pathways [27] . In addition, vitamin D deficiency and uremic toxins have been reported to promote IR in CKD [28] . Recently, Bellasi and colleagues have demonstrated that correction of metabolic acidosis improved IR in the CKD patients [29] . This study takes advantage of UPLC-MS-based metabonomics, a recently developed approach that has empowered us to quantitatively analyze the large number of metabolites uniquely associated with CKD, in an attempt to decipher the molecules and pathways unique to CKD-induced IR. To the best of our knowledge, this is the first study to directly compare metabolites in the target tissues of insulin in rat models of CKD-and HFDinduced rats. The CKD-induced IR rats in our study demonstrated resistance to insulin action or IR with significantly elevated levels of serum insulin and values of HOMA-IR compared to sham operation rats, whereas there was no significant difference in the levels of fasting blood glucose between the CKD and sham groups. The above features of CKD-induced IR in rats shared some similarities to those observed in patients with CKD-associated IR, who may maintain normoglycemia at the expense of hyperinsulinemia or who demonstrate normal or slightly elevated levels of fasting blood glucose. In the HDF-induced rats in our study, fasting glucose, insulin, and HOMA-IR were markedly increased, which was consistent with the previous findings in the high-fat or high-calorie diet-fed animal models to induce IR.
Our findings that alterations in metabolites of the serum, liver, and muscle tissues were significantly different between the CKD-and HFD-induced IR rats were consistent with previous studies. Notably, our study found that a decline in the rental function of CKD-IR rats exhibited significant effects on the pathways related to tryptophan and arginine metabolism, in contrast with HFD-induced IR rats. A disturbance in amino acid homeostasis has been found in relation to insulin resistance and β-cell function, and the abnormal metabolism of branched-chain amino acids (BCAAs) may even precede hyperglycemia later in life [30] . Interestingly, previous clinical and animal studies have suggested a role for the tryptophan (TRP)-kynurenine (KYN) pathway in insulin resistance, and increased levels of serum TRP and KYN could be a cause or a consequence of insulin resistance. For instance, serum levels of KYN were significantly elevated in diabetes retinopathy patients [31] , and excessive dietary TRP induced insulin resistance in pigs in another study [32] . A number of recent studies have demonstrated a strong association between the TRP-KYN pathway and IR, and the dysregulation of the TRP-KYN pathway was considered one of the mechanisms underlying the development of IR [33] [34] [35] [36] . Notably, we found that a significant up-regulation of the metabolites of the TRP-KYN pathway in the serum, liver, and muscle tissues suggests that the abnormality in the TRP-KYN pathway could be a contributing factor to the CKD-induced IR. Interestingly, our results also showed that levels of indole acrylic acid, KYN,5-hydroxyindole acetic acid, and others were decreased in the HFD-induced IR, indicating a disruption of the TRP-KYN pathway but displayed an opposite direction in the HFD-induced IR compared to the CKD-induced IR. As such, we postulated that the decline of renal function in CKD may directly perturb the TRP-KYN pathway, as well as other amino acids metabolisms, which may contribute to the mechanisms that at least in part underlay CKD-induced insulin resistance.
Our study has several strengths, such as newly identified metabolites and predicted molecular pathways in the liver and muscle, known as the main target organs of insulin, which were specially associated with CKD-induced IR in rats. However, it also has limitations. For instance, validating the disturbed molecular pathways and insights into their exact roles in CKD-induced IR are needed in our future research and are underway in our laboratory. Taken together, the results on the differential metabolites and pathways in CKD-induced IR and HFD-induced IR may offer important information regarding the pathogenesis in relation to IR caused by a decline in the renal function and a high-fat diet. They may also provide insight into the underlying molecular mechanisms. The findings may also lay the foundation for our future study of novel diagnostic, preventive, and therapeutic approaches.
